Login / Signup

The REDUCE-AMI trial: an important step in cardiovascular drug de-prescription.

Sean Van DiepenSigrun HalvorsenVenugopal Menon
Published in: European heart journal. Acute cardiovascular care (2024)
Keyphrases
  • acute myocardial infarction
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • open label
  • adverse drug
  • drug induced
  • emergency department
  • coronary artery disease